The strain SCSIO 03039 was isolated from a sediment sample in the Indian Ocean and was characterized as a Nocardiopsis alba species on the basis of its 16S rRNA gene sequence. Seven diketopiperazines (DKPs), including two new DKPs nocazines D (2a) and E (2b), and five known DKPs (1, 3-6), were isolated from N. alba SCSIO 03039, along with two known compounds 2-methoxy-1,4-naphthoquinone (7) and 1-hydroxy-4-methoxy-2-naphthoic acid (8). Their structures were elucidated by mass and NMR spectroscopic analyses. The structure of methoxyneihumicin (1), previously proposed in a conference poster lacking publicly available experimental data, was validated for the first time by detailed NMR analyses and X-ray diffraction study. The two enantiomers nocazines D (2a) and E (2b) were isolated as a mixture. Compounds 3 and 4 were only known as synthetic compounds before. Methoxyneihumicin (1) exhibited in vitro cytotoxicities against MCF-7 and SF-268 with IC 50 values of 4.6 and 12.7 mM, respectively, better than those of 6 (22.0 and 20.6 mM). The other compounds showed less pronounced cytotoxities against three tested human cancer cell lines and no compounds displayed antibacterial activities toward four indicator strains.
INTRODUCTION
Marine actinomycetes have been proven as a prolific resource for drug discovery. [1] [2] [3] However, reports of natural products derived from deepsea (41000 m) culturable actinomycetes are still scarce, probably because of the difficulty in accessing the deep-sea samples and the unculturability of deep-sea-derived actinomycetes. 4 Our recent investigations on deep-sea-derived actinomycetes have led to the discovery of culturable new actinobacterial taxa, [5] [6] [7] [8] [9] and the isolation of novel natural products, including spirotetronates, 10 b-carboline and indolactam alkaloids, 11 spiro-bisindole alkaloids, 12 diazaanthraquinone derivatives 13 and angucycline glycosides, 14 which exhibit antibacterial, anti-malarial and antitumor properties. From our numerous actinomycetes derived from deep-sea sediments, the isolate SCSIO 03039, identified as a Nocardiopsis alba, was found to produce seven diketopiperazines (DKPs), including two new DKPs nocazines D (2a) and E (2b), and five known DKPs (1, [3] [4] [5] [6] . Compound 1, methoxyneihumicin, previously reported in a conference poster without available experimental data, 15 was structurally validated herein for the first time by NMR analyses and the X-ray diffraction study. Compound 3 (S,Z)-3-benzylidene-6-methylpiperazine-2,5-dione and 4 (S,Z)-3-benzylidene -6-isopropylpiperazine-2,5-dione were only known as synthetic compounds before. 16 The two known DKPs, (3Z,6Z)-3-(4-methoxybenzylidene)-6-(2-methylpropylidene)-piperazine-2,5-dione (5) 17, 18 and XR334 (6), 19 were reisolated from N. alba SCSIO 03039. In addition, another two known compounds, 2-methoxy-1,4-naphthoquinone (7) 20, 21 and 1-hydroxy-4-methoxy-2-naphthoic acid (8) , 22 were also isolated. We reported herein the isolation, structure elucidation and biological activities of these compounds.
RESULTS AND DISCUSSION
Taxonomy of the producing strain The almost full 16S rRNA gene sequence (1447 bp) of the producing strain SCSIO 03039 was submitted to GenBank under the accession number JX195181, which showed the highest similarity (99.3%) to that of N. alba DSM 43377 T (X97883). The phylogenetic tree generated by a neighbor-joining method clearly revealed the evolutionary relationship of the strain SCSIO 03039 with a group of Nocardiopsis species (Supplementary Figure S1) . On the basis of the 16 S rRNA gene sequence analysis, 23 the strain SCSIO 03039 was designated as a species of N. alba.
Isolation of compounds 1-8
The fermentation broths of 20 l culture of N. alba SCSIO 03039 were extracted with butanone and the mycelia cakes were extracted with methanol, respectively. The combined crude extracts were subjected to various chromatographic methods (such as silica gel column, Sephadex LH-20 chromatography and semipreparative HPLC) and led to the isolation of two new DKPs nocazines D (2a) and E (2b), five known DKPs (1, 3-6), along with two known compounds 2-methoxy-1,4-naphthoquinone (7) and 1-hydroxy-4-methoxy-2-naphthoic acid (8) .
Structure elucidation
Compounds 5-8 ( Figure 1 ) were found to be known compounds (3Z,6Z)-3-(4-methoxybenzylidene)-6-(2-methylpropylidene)-piperazine-2,5-dione (5), 17, 18 XR334 (6), 19 2-methoxy-1,4-naphthoquinone (7) 20,21 and 1-hydroxy-4-methoxy-2-naphthoic acid (8), 22 respectively, by comparing their NMR data with those previously reported (Supplementary Figures S6-S9) .
The molecular formula of compound 1 was determined to be C 20 H 18 N 2 O 3 on the basis of high-resolution fast atom bombardment MS (HRFABMS) (m/z 335.1393 [M þ H] þ , calcd. for 335.1396). The 1 H and 13 C NMR data of 1 were very similar to those of nocazine A, 24 a metabolite isolated from the marine-derived Nocardiopsis dassonvillei HR10-5. The comparison of 1 H and 13 C NMR data between 1 and nocazine A revealed the loss of signals for one N-Me and one methoxy group in 1. The sets of coupled 1 H NMR signals at d H 7.43 (2H, ddd, J ¼ 8.0, 7.5, 1.8 H Z ), 7.37 (2H, brd, J ¼ 7.5 H Z ) and 7.32 (1H, tt, J ¼ 7.8, 1.5 H Z ) revealed the presence of one 1-substituted benzene in 1. HMBC correlations from H-7 to C-9/C-13 located the 1-substituted benzene at C-7 ( Figure 2 ). Thus, these comparisons indicated that 1 differed from nocazine A by losing N-1 methyl group and C-11 methoxy group (Figure 1) . The X-ray crystal diffraction analysis of 1 also supports this conclusion (Figure 3) , and further determined the Z configuration of both D 6,7 and D 3,14 double bonds. Thus, compound 1 was identified as (3Z, 6Z)-6-benzylidene-5-methoxy-3-(4-methoxybenzylidene)-1,6-dihydropyrazin-2(3H)-one (methoxyneihumicin, Figure 1 ). It should be noted that the structure of 1 was previously proposed in a conference poster without publicly available experimental data. 15 The molecular formula of compound 2 was determined to be C 19 The comparison of 1D NMR data of 2 with those of nocazine C 24 showed that 2 only differed from nocazine C by lacking signals for N-4 methyl group (N-1 methyl group in nocazine C). Correspondingly, C-2, C-3, C-5 and C-14 (C-5, C-6, C-2 and C-7, respectively, in nocarzine C 24 ) shifted upfield for 4.5, 4.7, 2.5 and 5.0 p.p.m., respectively. The planar structure of 2 ( Figure 1 ) was further confirmed by HMBC correlations from H-6 to C-2/C-5, from H-14 to C-2/C-5 and from H-7 to C-5/C-6 ( Figure 2 ). The D 3,14 double bond in 2 was deduced to be Z configuration from the relative downfield shift of H-14 (d H 6.81), in comparison with the vinyl proton chemical shifts of H-7 (d H 7.03) in nocazine C, 24 and H-7 (d H 6.54) in (3S,6E)-3-benzyl-6-benzylidenepiperazine-2,5-dione, 25 based on previous reports that the (Z)-vinyl proton was farther downfield than the (E)-vinyl proton because of the deshielding effect of the 5-ketone in DKP compounds. [24] [25] [26] [27] Consistent with the Z configuration of Table 1 ). The comparison of its NMR data with that of 2 revealed the existence of 3-benzylidenepiperazine-2,5-dione moiety, which were further identified by the HMBC correlations from H-7 to C-2/C-9, from H-9 to C-7/C-11 and from H-10 to C-8. In addition, the HMBC correlations from H-14 to C-5/C-6 located the methyl group (d H /d C 1.60/21.9) at C-6. Therefore, the planar structure of 3 was determined to be 3-benzylidene-6-methylpiperazine-2,5-dione ( Figure 1 Figure S11A) . Therefore, the structure of compound 3 was elucidated as (S, Z)-3-benzylidene-6-methylpiperazine-2,5-dione. The compound 3 was chemically synthesized before, 16 however, only 1 H NMR data were available. 16 The molecular formula of compound 4 was assigned to be C 14 Figure S11B) . Thus, compound 4 was elucidated as (S, Z)-3-benzylidene-6-isopropylpiperazine-2,5-dione (Figure 1 ). (Figure 2 ), exhibited less cytotoxic activities than 1. However, when the D 6,7 double bond in compound 6 was reduced to afford a mixture of 2a and 2b, the latter compounds showed little cytotoxic activities ( Table 2 ). The DKPs 3-5 and the compounds 7 and 8 exhibited little antiproliferative activities against the three tested cancer cell lines (Table 2 ). And no compounds displayed antibacterial activities (MIC4128 mg ml À1 ) against four indicator strains. DKPs are the smallest cyclic peptides known and exhibit a wide spectrum of biological activities with various therapeutic possibilities. 29, 30 Recently, marine actinomycetes have been emerged as producers for novel DKPs, such as cyclomarazines, 31 dimeric DKP naseseazines, 32 neihumicins, 33 nocardioazines (containing a novel bridged DKP scaffold), 34 nocazines, 24 and cyclo(2-hydroxy-Pro-RLeu). 35 However, none of the described producers were isolated from a deep-sea environment greater than the depth of 1000 m. In contrast, the strain N. alba SCSIO 03039 was isolated from the abyssal deep sedimental sample ( À3412 m) in the Indian Ocean. In this study, we showed that this deep-sea-derived actinomycete was capable of producing seven DKPs. Nocazines D and E (2a and 2b) were new. Methoxyneihumicin (1) was structurally validated for the first time by NMR and X-ray analyses. Compounds 3 and 4, previously known only as synthetic compounds, were isolated for the first time from a natural source. Interestingly, methoxyneihumicin (1) displayed cytotoxicities against MCF-7 and SF-268 with IC 50 values of 4.6 and 12.7 mM, significantly better than other DKPs isolated in this study.
Biological activity
Eight compounds (1-8) were evaluated for in vitro cytotoxic
METHODS

General experimental procedures
Materials for column chromatography were silica gel (100-200 mesh; 300-400 mesh; Jiangyou Silica Gel Development, Inc., Yantai, China), Sephadex LH-20 (40-70 mm; Amersham Pharmacia Biotech AB, Uppsala, Sweden) and YMC*-GEL ODS-A (12 nm S-50 mm; YMC Company Ltd., Kyoto, Japan). TLC (0.1-0.2 mm or 0.3-0.4 mm) was conducted with precoated glass plates (silica gel GF 254 , 10-40 nm; Jiangyou Silica Gel Development, Inc.). Medium-pressure liquid chromatography was performed on automatic flash chromatography (EZ Purifier III; Leisure Science Co., Ltd., Shanghai, China). ESI-MS was acquired on a MDS SCIEX API 2000 liquid chromatography/tandem MS (LC/ MS/MS) instrument (Applied Biosystems, Inc., Forster, CA, USA). HRFABMS data were obtained on a quadrupole-time-of-flight MS (Waters, Milford, MA, USA). The optical rotation was recorded on a 341 Polarimeter (PerkinElmer, Inc., Norwalk, CT, USA). UV spectra were recorded on an U-2900 spectrophotometer (Hitachi, Tokyo, Japan). The analytical chiral packed column Chiralpak AD-H (250 Â 4.6 mm 2 ID, 5 mm) (Daicel Chemicals, Tokyo, Japan), and an Agilent 1200 series HPLC system (Agilent, Santa Clara, CA, USA) were used for the chirality analysis. 1 H, 13 C NMR and 2D NMR spectra were recorded on a Bruker AV-500 NMR spectrometer (Bruker Biospin GmbH, Rheinstetten, Germany) with tetramethylsilane (d 0.0 p.p.m.) as the internal standard. 1 H NMR data were reported as follows: chemical shift (multiplicity: singlet (s), doublet (d), triplet (t) and multiplet (m)), coupling constants (Hz); 13 C NMR data were reported as follows: chemical shift (quaternary carbon (C), methine (CH), methylene (CH 2 ), methyl (CH 3 )). Deuterated NMR solvents were purchased from Cambridge Isotopes (Andover, MA, USA)
Isolation and taxonomic studies of the strain SCSIO 03039
A sediment sample was collected aseptically with a grab-bucket collection sampler from the location (E 87159. Figure S1) were performed as described previously. 5 Fermentation of the strain SCSIO 03039, extraction and isolation of secondary metabolites A single colony of SCSIO 03039 on ISP 4 medium (soluble starch 1%, K 2 HPO 4 0.1%, MgSO 4 Á 7 H 2 O 0.1%, (NH 4 ) 2 SO 4 0.2%, CaCO 3 0.2%, sea salt 3%, pH 7.0-7.4 before sterilization) was inoculated into a 250-ml Erlenmeyer flask containing 30 ml of the seed medium (soluble starch 2%, glucose 1%, bacterial protein 0.5%, yeast exact 0.5%, CaCO 3 0.2%, sea salt 3%, pH 7.0 before sterilization). After incubating on a rotary shaker (200 r.p.m.) for 3 days at 28 1C, the pre-cultures were transferred to 1000-ml Erlenmeyer flask containing 200 ml of the seed medium. A total of 20 l cultures were made by this way. Fermentations were done on a rotary shaker (200 r.p.m.) for 7 days at 28 1C. The 20-l fermentation broths were extracted four times with 20 l butanone, and the mycelia cakes were extracted four times with 4 l methanol. After removing solvents, both residues from fermentation broths and mycelia cakes were combined to afford 11.86 g crude extracts.
The crude extracts were subjected to normal phase silica gel column (100-200 mesh, 90 g) and eluted with CHCl 3 /CH 3 OH (100/0, 100/1, 100/2, 100/4, 100/8, 100/16, 100/32 and 0/100, v/v, each of 360 ml) to yield eight fractions (Fr.1-Fr.8). Fr.1 and Fr.2 were combined and subjected to Sephadex LH-20 chromatography and were eluted with CHCl 3 /CH 3 OH (1:1) to give six subfractions (Fr.1-1-Fr.1-6). Fr.1-2 (23.7 mg) was further purified by semipreparative HPLC on a Varian Star Workstation, using a reversed phase column C18 (YMC*GEL ODS-A, 120 A S-5 mm, 250 Â 10 mm 2 ; solvent A, 0.1% formic acid in water; solvent B, 90% acetonitrile in water; eluted with constant 70% solvent B) to obtain compounds 7 (2.9 mg) and 8 (3.0 mg). New diketopiperazine derivatives Q Zhang et al Determining the absolute configuration of amino acids in compounds 2-4 by Marfey's method
The FDAA derivatized hydrolysates of compounds 2 (0.50 mg), 3 (0.50 mg) and 4 (0.58 mg), and the standard amino acids were prepared according to the published method. 24 The FDAA derivatives were then subjected to HPLC analysis (Luna C 18 column; 5 mm, 4.6 Â 150 mm 2 ) using the following solvent system: solvent A, 10% acetonitrile in water supplementing with 0. 
Chiral analysis of compound 2
The solution of 2 in methanol was subjected to HPLC analysis (Chiralpak AD-H, 250 Â 4.6 mm 2 , ID 5mm) (Daicel Chemicals) on an Agilent 1200 series HPLC system, eluted with 20% 2-propanol in n-hexane, UV detection at l ¼ 254 nm. 
Biological activity
Antibacterial activities were evaluated against bacterial strains S. aureus ATCC 29213, Enterococcus faecalis ATCC 29212, B. subtilis SCSIO BS01 and B. thuringiensis SCSIO BT01 according to previously described methods. 36 Cytotoxic activities were determined against three tumor cell lines, including MCF-7 cells (human breast adenocarcinoma cell line), NCI-H460 (human non-small cell lung cancer cell line) and SF-268 (human glioma cell line), according to published protocols. 37 
